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SUMMARY
Introduction/Objective The objective of this paper was to increase the effectiveness of pharmacological 
correction of retinal ischemia-reperfusion by using minoxidil.
Methods The research was carried out on 180 Wistar rats. A modification of the retinal ischemia-reperfu-
sion model was used, in which an increase in intraocular pressure is carried out by mechanical pressure 
(110 mmHg) to the front chamber of the eye for 30 minutes. Protective effects of minoxidil at a dose 0.5 
mg/kg on the model of retinal ischemia-reperfusion were estimated by the changes in the level of retinal 
microcirculation (laser Doppler flowmetry), electroretinogram amplitude, morphometry of retinal layers 
after 1 hour and 72 hours of reperfusion.
Results Minoxidil at a dose 0.5 mg/kg of rat mass improves retinal microcirculation, its electrophysi-
ological state after 1 hour and 72 hours of reperfusion, and prevents the development of degenerative 
changes in the retina caused by ischemic damage to a greater extent than recombinant erythropoietin 
at a dose of 50 IU/kg and sildenafil at a dose of 0.5 mg/kg in monotherapy. The protective effects of 
minoxidil were eliminated by the preliminary administration of glibenclamide at a dose of 5 mg/kg, 
which indicates the presence of the preconditioning effect of minoxidil, realized through adenosine 
triphosphate-dependent potassium channels.
Conclusion Minoxidil at a dose of 0.5 mg/kg of rat mass protects the retina from ischemic-reperfusion 
injury. Protective effects of minoxidil are carried out by a preconditioning action, as evidenced by the 
lack of positive effects with the administration of glibenclamide.
Keywords: ischemia-reperfusion; retina; minoxidil; erythropoietin; sildenafil; ATP-dependent potassium 
channels
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INTRODUCTION
Local circulatory disorders in the branches 
of retinal artery are observed in diabetic reti-
nopathy, hypertensive retinopathy, degenera-
tive diseases of the retina, optic nerve atrophy 
vascular origin, traumatic eye injury, ischemic 
neuropathy [1, 2, 3].
Studying the way of how to improve tissue 
tolerance to ischemia is an actual problem of 
modern experimental and clinical pharmacolo-
gy. Up to now, the treatment of ischemic retinal 
conditions was done by use of angioprotectors, 
antioxidants, fibrinolytics, anticoagulants and 
others. As the authors note, due to the insta-
bility and short-term effects after using these 
drugs in combination with other drugs and 
physiotherapy treatments is necessary to seek 
out a more effective way to improve blood cir-
culation and increase resistance to ischemic 
retinal tissue having a specific orientation [4].
Thus, an important task is to find new, spe-
cific and highly effective means for correcting 
of retinal ischemia.
Therefore, the objective of the study is to 
increase the effectiveness of pharmacological 
correction of retinal ischemia-reperfusion by 
using minoxidil.
METHODS
Experiments were carried out on 180 Wistar 
rats weighing 250 ± 25 g. For the study, the rats 
were taken with no external signs of disease, 
passed quarantine regime.
Ethical principles of handling laboratory 
animals were observed in accordance with the 
European Convention for the Protection of 
Vertebral Animals Used for Experimental and 
Other Scientific Purposes, CETS No. 123.
Minoxidil, 0.5 mg/kg, was administered 
intragastrically (i/g) once 1 hour before isch-
emia-reperfusion modeling.
Recombinant erythropoietin (EPO) was 
administered intraperitoneally (i/p) once at a 
dose of 50 IU/kg 30 minutes before pathology 
modeling for the purpose of preconditioning 
as a reference drug [5].
Animals received i/p injection of sildenafil 
at a dose of 0.5 mg/kg once 30 minutes before 
pathology modeling.
Glibenclamide was administered at a dose 
of 5 mg/kg i/g once 1 hour before ischemia-
reperfusion modeling.
Ischemia-reperfusion injury of the retina was 
simulated under anesthesia (chloral hydrate, 300 
mg/kg of animal body weight, i.p.) by applying 
mechanical pressure (110 mmHg) to the ante-
rior eye chamber for 30 minutes [4].
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The experiment included two series of animals (with an 
assessment of the parameters after 1 hour and 72 hours of re-
perfusion), nine groups in each series, 10 rats in each group.
The measuring of the level of retinal microcirculation 
of rats was carried out by laser Doppler flowmetry (LDF) 
after 1 hour and 72 hours of reperfusion [6]. Registration 
was carried out by MP150 data acquisition and analysis 
systems and the TSD144 needle-type sensor, with Ac-
qKnowledge 4.2 software (BIOPAC Systems, Inc., Goleta, 
CA, USA). After animal anesthesia, assessment of mi-
crocirculation level was carried out at 10 points on the 
circumference of the eyeball; the recording duration of 
the microcirculation level readings at one point was 20 
seconds. From the microcirculation level results at every 
point, the average value was calculated, which was taken as 
the indicator of the microcirculation level in the retina of 
the experimental animal. The value of microcirculation in 
the animal group was calculated as the average of the val-
ues obtained from each experimental animal in the group.
To perform electroretinography (ERG), after 1 hour and 
72 hours of reperfusion, rats were kept in the dark for 30 
minutes, then, anesthetized (chloral hydrate, 300 mg/kg, 
i/p), and fixed on the table isolated from electromagnetic 
radiation [7]. Strobe flash of white light that was connect-
ed to the STM200 stimulator (Biopac Systems, Inc.) and 
placed behind the animal; ERG registration was carried 
out in response to a single stimulation. Evoked biopo-
tentials were run at a frequency of 1–1000 Hz, amplified, 
averaged, and presented graphically on the screen using 
the MP150 data acquisition and analysis system and the 
aforementioned software. The ERG recording was carried 
out for 0.5 seconds in each rat in the groups. To assess the 
degree of retinal ischemia, the ratio of the amplitudes of 
the a- and b-waves of ERG, the coefficient b/a was evalu-
ated [7]. From 10 values received, the mean was derived 
for each group, which was introduced into the protocol.
After the LDF and ERG, eyes with surrounding tissues 
were subjected to enucleation in both series of experi-
ments. Eyes with immediately adjacent tissues were fixed 
in 10% formalin solution for histological research. After 
fixation, the eyes were cut into two parts in the meridian 
direction strictly through the center, and both halves were 
poured into paraffin according to the standard procedure. 
Sections for the standard histological examination were 
stained with hematoxylin-eosin. A descriptive study of his-
tological preparations was performed under a Axio Scope 
A1 microscope (Carl Zeiss Microscopy GMbH, Jena, Ger-
many). The morphometric studies were performed on the 
Mikmed-5 microscope with the use of the Micro-Analysis 
View software (LOMO, JSC, Saint Petersburg, Russia) [8].
RESULTS
After the pathology modeling after 1 hour and 72 hours of 
reperfusion, microcirculation was measured in the retina by 
LDF, electrophysiological condition of the retina was deter-
mined by ERG, the extirpation of animals and enucleation 
of the eyes for morphological studies was carried out.
After the pathology modeling, microcirculation level 
measurement was performed after 1 hour and 72 hours 
of reperfusion by LDF. The results obtained after 1 hour 
of reperfusion are presented in Table 1.
Table 1. The level of retinal microcirculation after 1 h and 72 hour of 
reperfusion (M ± m), perfusion units
No. Experimental groups
Level of 
microcirculation 
after 1 hour of 
reperfusion,
PU (n = 10)
Level of 
microcirculation 
after 72 hours of 
reperfusion, PU
(n = 10)
1 Intact 738.9 ± 37.6 743.9 ± 5.0
2 Control (ischemia) 1,155.0 ± 51.9* 353.3 ± 11.7*
3 Control + MIN 751.3 ± 21.8у 739.5 ± 14.1у
4 Control + EPO 798.5 ± 12.3у 724.0 ± 4.1у
5 Control + SIL 832.3 ± 20.1у 711.5 ± 15.3у
6 Control + Glib 1,135.8 ± 31.2* 359.4 ± 10.3*
7 Control + MIN + Glib 1,149.8 ± 18.6* 361.1 ± 10.9*
8 Control + EPO + Glib 1,148.3 ± 15.3* 372.3 ± 13.4*
9 Control + SIL + Glib 1,151.2 ± 31.9* 360.3 ± 12.1*
Glib – glibenclamide; SIL – sildenafi l; PU – perfusion units; MIN – minoxidil; 
EPO – recombinant erythropoietin; 
*p < 0.05 compared to intact rats;
уp < 0.05 compared to the control group
The level of microcirculation after ischemia modeling 
in the control group reached 1,155.0 ± 51.9 PU after 1 hour 
of reperfusion, which was significantly higher than the 
value in the group of intact animals (p < 0.05).
With the correction of pathology by minoxidil (MIN), 
microcirculation level in the retina after 1 hour of reperfu-
sion decreased to 751.3 ± 21.8 PU, which was significantly 
different from the control group (p < 0.05).
With the correction of pathology by EPO, microcircula-
tion level in the group was reduced to 798.5 ± 12.3 PU and 
was significantly different from the values in the control 
group (p < 0.05).
Introduction of glibenclamide, a blocker of adenos-
ine triphosphate-sensitive (ATP-sensitive) potassium 
channels, prevented the reduction of microcirculation 
in groups with correction by MIN, EPO, sildenafil (SIL); 
this confirms the preconditioning action of these drugs in 
studied doses on retinal ischemia-reperfusion model on 
rats after 1 hour of reperfusion.
The level of microcirculation after the pathology mod-
eling in the control group after 72 hours of reperfusion 
was 353.3 ± 11.7 PU, which was significantly lower than 
in the group of intact animals (p < 0.05). In the group with 
the correction by MIN, this rate increased to 739.5 ± 14.1 
PU (p < 0.05), which was significantly different from the 
values in the control group. 
Correction of the modeled pathology by EPO led to an 
increase of microcirculation level in the group to 724.0 ± 
4.1 PU, which was significantly different from the values 
in the control group (p < 0.05).
Introduction of glibenclamide in groups with MIN-cor-
rection, EPO-correction, and SIL-correction prevented the 
improvement of the microcirculation level after 72 hours 
of reperfusion.
Pharmacological correction of retinal ischemia/reperfusion by minoxidil
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After the pathology modeling and measuring of micro-
circulation level in the retina, ERG on evoked potential 
was performed. The results obtained after 1 hour and 72 
hours of reperfusion are shown in Table 2.
Table 2. Results of evaluation of electrophysiological retinal function 
after 1 hour and 72 hours of reperfusion (M ± m)
No. Experimental groups
Ratio b/a after 
1 hour of 
reperfusion
(n = 10)
Ratio b/a after 
72 hours of 
reperfusion
(n = 10)
1 Intact 2.6 ± 0.09у 2.5 ± 0.10у
2 Control (ischemia) 2.0 ± 0.09* 1.2 ± 0.04*
3 Control + MIN 2.5 ± 0.06у 2.4 ± 0.09у
4 Control + EPO 2.5 ± 0.10у 2.3 ± 0.06у
5 Control + SIL 2.4 ± 0.09*у 2.3 ± 0.09у
6 Control + Glib 2.0 ± 0.08* 1.3 ± 0.04*
7 Control + MIN + Glib 2.1 ± 0.09* 1.3 ± 0.06*
8 Control + EPO + Glib 2.1 ± 0.09* 1.2 ± 0.07*
9 Control + SIL + Glib 2.0 ± 0.08* 1.2 ± 0.08*
MIN – minoxidil; EPO – recombinant erythropoietin; Glib – glibenclamide; 
SIL – sildenafi l; 
*p< 0.05 compared to intact rats; уp < 0.05 compared to the control group
The b/a ratio in the control group was 2.0 ± 0.09 after 1 
hour of reperfusion, which was significantly different from 
the values in the group of intact animals (p < 0.05). In the 
group of animals with the correction by MIN, the b/a ratio 
was 2.5 ± 0.06 after 1 hour of reperfusion, which was signifi-
cantly different from the group’s ratio with retinal ischemia 
and approached the values in the group of intact animals 
(p < 0.05). An increase of this indicator in the group with 
the correction by EPO to 2.5 ± 0.10, by SIL up to 2.4 ± 0.09 
after 1 hour of reperfusion, confirms the saving of retinal 
electrophysiological function after the pathology modeling. 
The b/a coefficient in the control group after 72 hours 
of reperfusion was 1.2 ± 0.04, which was significantly 
different from that of the group of intact animals. In the 
group of animals with the correction by MIN, the b/a ra-
tio was 2.4 ± 0.09, which was significantly different from 
that of the group with retinal ischemia (p < 0.05) and ap-
proached the values in the group of intact animals. The 
increase of this indicator in the group with the correction 
by EPO to 2.3 ± 0.06, SIL up to 2.3 ± 0.09 confirms the 
maintaining of electrophysiological retinal function after 
the pathology modeling. 
Introduction of glibenclamide in groups with correc-
tions by MIN, EPO, and SIL in monotherapy decreased the 
b/a ratio to values significantly different from the group of 
intact rats, indicating the blockade of the ATP-dependent 
potassium channels.
A decrease in the b/a ratio in animals with ischemia 
(control) due to inhibition of the positive b-wave of ERG 
indicates a violation of electrophysiological function of 
bipolar and Muller cells with the possible contribution of 
the horizontal and amacrine cells. Saving the electrophysi-
ological function of the photoreceptor layer is confirmed 
by the absence of changes in the negative a-wave.
During the morphometric analysis of the thickness of 
the inner nuclear layer and a layer of photoreceptors, the 
increase of thickness of the inner nuclear layer was deter-
mined to amount to 25.9 ± 0.6 μm in the control group after 
1 hour of reperfusion, which is significantly different from 
the values in the group of intact rats (p < 0.05) (Table 3).
In groups with the MIN-correction, the thickness of 
the inner nuclear layer was 23.7 ± 0.6 μm after 1 hour of 
reperfusion, which differs significantly from the values of 
the control group (p < 0.05). Prior administration of EPO 
reduced the thickness of the inner nuclear layer to 23.8 ± 
0.6 μm, which was significantly different from the control 
group and approached the values in the group of intact 
animals (p < 0.05). In groups with the SIL-correction, the 
thickness of the inner nuclear layer was 24.0 ± 0.7 μm after 
1 hour of reperfusion, which also differs significantly from 
the values of the control group (p < 0.05).
Prior administration of glibenclamide in groups with 
the MIN-correction, EPO-correction, and SIL-correction, 
after 1 hour of reperfusion, led to an increase of the thick-
ness of the inner nuclear layer – group values were 25.7 
± 0.6 μm, 25.3 ± 0.4 μm, and 25.7 ± 0.5 μm, respectively.
The inner nuclear layer thickness was 20.3 ± 0.8 μm 
after 72 hours in the control group, which is significantly 
different from the group of intact animals (p < 0.05). In 
the group of animals with MIN and EPO, the inner nuclear 
layer thickness after 72 hours of reperfusion was 23.5 ± 0.5 
μm and 23.3 ± 0.7 μm, respectively, which is significantly 
different from the values of the group with ischemia. In 
the group with SIL, the inner nuclear layer thickness was 
22.7 ± 0.6 μm, which also differed significantly from the 
values of the control group (p < 0.05).
Table 3. Morphometric values of retinal layers of experimental animals after 1 hour and 72 hours of reperfusion (M ± m)
No. Experimental groups
1 hour of reperfusion (n = 10) 72 hours of reperfusion (n = 10)
Thickness of the inner 
nuclear layer [μm]
Thickness of the 
photoreceptor layer [μm]
Thickness of the inner 
nuclear layer [μm]
Thickness of the 
photoreceptor layer [μm]
1 Intact 23.5 ± 0.8y 38.4 ± 0.8 23.8 ± 1.0у 38.1 ± 1.2
2 Control (ischemia) 25.9 ± 0.6* 39.1 ± 0.7 20.3 ± 0.8* 36.9 ± 0.9
3 Control + MIN 23.7 ± 0.6у 38.4 ± 0.9 23.5 ± 0.5у 37.9 ± 0.9
4 Control + EPO 23.8 ± 0.6y 38.6 ± 0.9 23.3 ± 0.7у 38.0 ± 1.0
5 Control + SIL 24.0 ± 0.7y 39.1 ± 0.6 22.7 ± 0.6у 37.3 ± 0.7
6 Control + Glib 25.8 ± 0.6* 39.2 ± 0.6 20.6 ± 0.6* 36.9 ± 0.9
7 Control + MIN + Glib 25.7 ± 0.6* 39.0 ± 0.5 20.3 ± 0.5* 37.2 ± 1.0
8 Control + EPO + Glib 25.3 ± 0.4* 38.6 ± 0.6 20.5 ± 0.5* 37.6 ± 1.1
9 Control + SIL + Glib 25.7 ± 0.5* 39.0 ± 0.7 20.5 ± 0.8* 38.0 ± 1.2
MIN – minoxidil; EPO – recombinant erythropoietin; Glib – glibenclamide; SIL – sildenafi l; 
*p < 0.05 compared to intact rats; уp < 0.05 compared to the control group
Peresypkina A. A. et al.
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DISC USSION
The search of new methods of retinoprotection for possible 
reduction of the damaging effect of ischemia, formed in 
various systemic diseases, is an urgent task of pharmacol-
ogy and ophthalmology. Segment of drugs for the treatment 
of vascular diseases of the eye such as complication from 
hypertension, diabetes, and others, would be expedient to 
expand due to an increase in morbidity and lack of funds 
for targeted correction of ischemic lesions of the eye vessels.
Based on the fact that electrophysiological studies often 
have a decisive importance in the early and differential 
diagnosis of retinal disorders, to study the correction of 
functional changes in the retina, researcher must conduct 
a comprehensive analysis, including electroretinography 
and microcirculation research [9]. Analysis of the dynam-
ics of retinal electrogenesis allows to evaluate the nature 
and topography of retinal disorders and to identify the 
most labile hypoxic retinal structure, as well as their reac-
tion to the correction by the medications.
The most pronounced retinal protective action was ob-
served in groups with pharmacological preconditioning 
by minoxidil at a dose of 0.5 mg/kg after 1 hour and 72 
hours of reperfusion.
A single i/g injection of minoxidil at a dose of 0.5 
mg/kg, 60 minutes before modeling of retinal ischemia-
reperfusion, significantly reduced the level of retinal 
microcirculation after 1 hour of reperfusion, and saved 
the retinal electrophysiological activity, which was also 
confirmed by morphometrics of retinal layers. We found 
that minoxidil prevents the retinal layers’ damages caused 
by ischemic injury to a greater extent than recombinant 
erythropoietin at a dose of 50 IU/kg and sildenafil at a dose 
of 0.5 mg/kg in monotherapy after 1 hour of reperfusion 
and degenerative changes of retinal layers after 72 hours 
of reperfusion. 
Prior administration of glibenclamide at a dose of 5 mg/
kg eliminated the positive effects of minoxidil, erythropoi-
etin, and sildenafil, which confirms the implementation of 
retinal protection by preconditioning with the participa-
tion of ATP-dependent potassium channels.
CONCLUSION
Minoxidil at a dose of 0.5 mg/kg protects the retina from 
ischemic-reperfusion injury better than recombinant 
erythropoietin at a dose of 50 IU/kg and sildenafil at a 
dose of 0.5 mg/kg in monotherapy.
Protective effects of minoxidil are carried out by a pre-
conditioning action as evidenced by the lack of positive 
effects with administration of glibenclamide.
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САЖЕТАК
Увод/Циљ Циљ студије јесте да се побољша ефикасност 
фармаколошке корекције исхемије-реперфузијe мрежњаче 
миноксидилом.
Методе Истраживање је спроведено на 180 пацова врсте 
вистар. Коришћена је модификација модела исхемије-ре-
перфузије, при чему се повећање интраокуларног притис-
ка вршило механичким притиском (110 mmHg) на предњу 
комору ока у трајању од 30 минута. Заштитни ефекти ми-
ноксидила у дози од 0,5 mg/kg процењене су на основу про-
мена микроциркулације мрежњаче (ласерска доплер-фло-
уметрија), амплитуде електроретинограма, морфометрије 
слојева мрежњаче после једног и 72 сата од реперфузије.
Резултати Миноксидил у дози од 0,5 mg/kg масе пацова 
побољшава микроциркулацију мрежњаче, њено електро-
физиолошко стање после једног и 72 сата реперфузије и 
спречава развој дегенеративних промена слојева мрежњаче 
изазваних исхемијом више него монотерапија рекомбинант-
ним еритропоетином у дози од 50 IU/kg и силденафилом у 
дози од 0,5 mg/kg. Заштитно дејство миноксидила елими-
нише се давањем глибенкламида у дози од 5 mg/kg, што 
доказује прекондиционирани ефекат код миноксидила, који 
је остварен кроз АТП-зависне калијумове канале.
Закључци Миноксидил у дози од 0,5 mg/kg штити мрежњачу 
од исхемије / реперфузионе повреде. Заштитни ефекат ми-
ноксидила се реализује посредством прекондиционирања, 
што доказује недостатак позитивних ефеката на примену 
глибенкламида.
Кључне речи: исхемија-реперфузија; ретина; миноксидил; 
еритропоетин; силденафил; АТП-зависни канали калијума
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